Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.
Emerg Infect Dis
; 28(2): 463-465, 2022 02.
Article
in English
| MEDLINE | ID: covidwho-1650757
ABSTRACT
Population-based data on coronavirus disease in Russia and on the immunogenicity of the Sputnik V vaccine are sparse. In a survey of 1,080 residents of Arkhangelsk 40-75 years of age, 65% were seropositive for IgG. Fifteen percent of participants had been vaccinated; of those, 97% were seropositive.
Keywords
Arkhangelsk; Belova N; COVID-19; Kudryavtsev A; Postoev V; Russia; Russia. Emerg Infect Dis. 2022 Feb [date cited]. https://doi.org/10.3201/eid2802.211640; SARS-CoV-2; Shagrov L; Sharashova E; Suggested citation for this article: Krieger E; antibodies; epidemiology; et al. Seroprevalence of SARS-CoV-2 antibodies in adults; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Type of study:
Observational study
Topics:
Vaccines
Limits:
Adult
/
Humans
Country/Region as subject:
Asia
/
Europa
Language:
English
Journal:
Emerg Infect Dis
Journal subject:
Communicable Diseases
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS